FluoroPharma Medical, Inc. (OTCQB: FPMI)
FluoroPharma Medical, Inc. (FPMI) engages in the discovery, development and commercialization of proprietary medical diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography (PET) imaging agents for the efficient detection and assessment of acute and chronic forms of coronary artery disease (CAD).
FluoroPharma Medical, Inc.
Vstock Transfer, LLC
Wolf & Company, P.C.